5th Circ. Judge Skeptical Of Medicare Drug 'Price-Setting'
By Theresa Schliep · May 1, 2024, 5:15 PM EDT
A Fifth Circuit judge on Wednesday sharply criticized the Biden administration's Medicare drug pricing program, characterizing it as government "price-setting" and questioning "what possible procompetitive justification" there can be for penalizing...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login